HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE
Switzerland
17784795.1
Filed on 2017-10-03
17784795.1
Filed on 2017-10-03
HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE
Belgium
17784795.1
Filed on 2017-10-03
17784795.1
Filed on 2017-10-03
Anti-Coronavirus Antibodies And Methods Of Use
Pakistan
196/2021
Filed on 2021-03-08
196/2021
Filed on 2021-03-08
BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION
Hong Kong
42021036522.7
Filed on 2021-08-09
42021036522.7
Filed on 2021-08-09
STABILIZED NOROVIRUS VIRUS-LIKE PARTICLES AS VACCINE IMMUNOGENS
Patent Cooperation Treaty
PCT/US2021/055018
Filed on 2021-10-14
PCT/US2021/055018
Filed on 2021-10-14
Prefusion RSV F Proteins And Their Use
Mexico
MX/a/2021/010519
Filed on 2021-08-31
MX/a/2021/010519
Filed on 2021-08-31
Monoclonal Antibody Against Spike Protein Of Middle East Respiratory Syndrome Coronavirus And Uses Thereof
US Application 16/641,580
Filed on 2020-02-24
Filed on 2020-02-24
Monoclonal Antibody Against Spike Protein Of Middle East Respiratory Syndrome Coronavirus And Uses Thereof
Patent Cooperation Treaty
PCT/KR2018/009754
Filed on 2018-08-23
PCT/KR2018/009754
Filed on 2018-08-23
Monoclonal Antibody Against Spike Protein Of Middle East Respiratory Syndrome Coronavirus And Uses Thereof
South Korea
10-2017-0106836
Filed on 2017-08-23
10-2017-0106836
Filed on 2017-08-23